Skip to content


Temodar, Temodal (temozolomide) is a small molecule pharmaceutical. Temozolomide was first approved as Temodar on 1999-01-26. It is used to treat glioblastoma and melanoma in the USA. It has been approved in Europe to treat glioblastoma and glioma. Temodal's patent is valid until 2023-09-08 (FDA).
Trade Name Temodal
Common Name Temozolomide
Indication glioblastoma, glioma, melanoma
Drug Class
Get full access now